Each softgel contains:
Saw Palmetto Extract (Serenoa repens) (85% fatty acids) (fruit)...........80 mg
Nettle Extract 10:1 (Urtica dioica) (root)..................................................75 mg
Beta-Sitosterol (Glycine max) (seed).....................................................100 mg
Pumpkin Seed Oil (Cucurbita pepo) (seed)...........................................100 mg
Rye Extract 20:1 (Secale cereale) (from 2000 mg flower pollen).........100 mg
Pygeum (Prunus africana) (stem and trunk bark) (13% phytosterols)....20 mg
Zinc (bisglycinate)...................................................................................7.5 mg
Wild Hydrangea Extract 4:1 (Hydrangea arborescens) (root)................2.5 mg
Lycopene (Solanum lycopersicum) (fruit flesh)......................................1.5 mg
Copper (gluconate)..............................................................................500 mcg
Non-medicinal ingredients: Softgel (gelatin, glycerin, purified water, carob, titanium dioxide), soybean oil, yellow beeswax, lecithin.
Recommended adult dose: 2 softgels 2 times daily or as directed by a health care practitioner. For occasional use only, if used as a diuretic. Consult a health care practitioner for use beyond 24 weeks.
Cautions: Not intended for use by women. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use to exclude a diagnosis of prostate cancer. Hypersensitivity, such as allergy, has been known to occur, in which case discontinue use. Keep out of reach of children.
This product does not contain artificial preservatives, colours, or sweeteners; no dairy, sugar, wheat, gluten, yeast, egg, fish, shellfish, salt, tree nuts, or GMOs.
References
Cicero, A.F.G., Allkanjari, O., Busetto, G.M., et al. (2019). Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer. Arch Ital Urol Androl, 91(3), 139-52.
Hong, H., Kim, C.-S., & Maeng, S. (2009). Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutr Res Pract, 3(4), 323-7.
Pagano, E., Laudato, M., Griffo, M., et al. (2014). Phytotherapy of benign prostatic hyperplasia. A mini review. Phytother Res, 28(7), 949-55.
Safarinejad, M.R. (2005). Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study. J Herb Pharmacother, 5(4), 1-11.
Sauer, A.K., Vela, H., Vela, G., et al. (2020). Zinc deficiency in men over 50 and its implications in prostate disorders. Front Oncol, 10, 1293.
Sudeep, H.V., Thomas, J.V., & Shyamprasad, K. (2020). A double-blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency. BMC Urol, 20(1), 86.
Wilt, T., Ishani, A., MacDonald, R., et al. (2002). Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev, 1998(1), CD001044.
Ye, Z., Huang, J., Zhou, L., et al. (2019). Efficacy and safety of Serenoa repens extract among patients with benign prostatic hyperplasia in China: a multicenter, randomized, double-blind, placebo-controlled trial. Urology, 129, 172-9.
Customer Feedback (0)